Dose Accumulation for Pelvic Stereotactic Ablative Radiotherapy Reirradiation
This study has demonstrated feasibility of per-voxel anatomically and radiobiologically appropriate 3-dimensional evaluation of cumulative normal tissue doses in patients previously treated with pelvic SABR reirradiation. No toxicity events could be attributed to the cumulative or reirradiation doses delivered.
Authors
- Catherine O’Hara
- J. Lilley (ORCID: https://orcid.org/0000-0003-0060-0316)
- Marcus Tyyger (ORCID: https://orcid.org/0000-0001-8491-1298)
- Lesley Murray (ORCID: https://orcid.org/0000-0001-7563-3695)
- J Entwisle
- Finbar Slevin (ORCID: https://orcid.org/0000-0002-7176-904X)
- Ane Lindegaard Appelt (ORCID: https://orcid.org/0000-0003-2792-9218)
- Christopher Thompson (ORCID: https://orcid.org/0000-0001-7447-408X)
- Matthew Nix
Institutions
- Leeds Teaching Hospitals NHS Trust (GB)
Publication Details
- Journal
- Clinical Oncology
- Published
- 2025-05-09
- DOI
- https://doi.org/10.1016/j.clon.2025.103861
- Citations
- 2
- Primary Topic
- Advanced Radiotherapy Techniques
- Type
- article
- Field-Weighted Citation Impact
- 3.77
Funders
- Cancer Research UK